1026
G. Kacprzak, J. Kołodziej
20. Erasmus JJ, Goodman PC, Patz EP: Management of malignant pleural effusion and pneumothorax. Radiol Clin North Am 2000; 38(2): 375-83. 21. Antunes G, Neville E: Management of malignant pleural effusions. Thorax 2000; 55: 981-83. 22. Gravelyn TR, Michelson MK, Gross BH i wsp.: Tetracycline Pleurodesis for Malignant Pleural Effusions. A 10-Year Retrospective Study. Cancer 1987; 59: 1973-77. 23. Oszko M: Pleural effusions: pathophysiology and management with intrapleural tetracycline. Drug Intell Clin Pharm 1988; 22: 15-19. 24. Morrison MC, Mueller PR, Lee MJ i wsp.: Sclerotherapy of malignant pleural effusion through sonographically placed small-bore catheters. AJR 1992; 158(1): 41-43. 25. Gust R, Kleine P, Fabel H: Fibrin glue and tetracycline pleurodesis in reccuring malignant pleural effusion - A randomized comparative study. Medizinische Klinik 1990; 85(1): 18-23. 26. Landvater L, Hix WR, Mills M i wsp.: Malignant Pleural Effusion Treated by Tetracycline Sclerotherapy. A Comparison of Single vs Repated Instillation. Chest 1988; 93(6): 1196-98. 27. Yamaguchi E, Nagai A, Sakamoto K i wsp.: Morphological changes in the pleura caused by intracavitary administration of bleomycyn. Gan To Kagaku Ryoho 1991; 18(6): 971-75. 28. Paladine W, Cunningham TJ, Sponzo R i wsp.: Intracavitary bleomycin in the management of malignant effusions. Cancer 1976; 38(5): 1903-08. 29. Saka H, Watanabe A, Horio Y i wsp.: A phase II study of bleomycin pleurodesis in Japan. Am Rev Respir Dis 1991; 143(4): pt.2 A661. 30. Ostrowski MJ, Halsal GM: Intracavitary bleomycin in the management of malignant effusions: a multicenter study. Cancer Treat Rep 1982; 66: 1903-07. 31. Sugita T, Matsunaga K, Kobayashi H i wsp.: Intrapleural bleomycin for management of malignant pleural effusions. Gan To Kagaku Ryoho 1995; 22(9): 1203-07. 32. Ostrowski MJ: Intracavitary therapy with bleomycin for the treatment of malignant pleural effusions. J Surg Oncol Suppl 1989; 1: 7-13. 33. Bitran JD, Brown C, Desser RK i wsp.: Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol 1981; 16(3): 273-77. 34. Goff BA, Mueller PR, Muntz HG i wsp.: Small chest-tube drainage followed by bleomycin sclerosis for malignant pleural effusions. Obstet Gynecol 1993; 81(6): 993-96. 35. Ostrowski MJ: An assessment of the long-term results of controlling the reaccumulation of malignant effusion using intracavity bleomycin. Cancer 1986; 57(4): 721-27. 36. Ferdoutsis E, Bouros D, Meletis G i wsp.: A comparative study of intrapleural instillation of bleomycin vs alpha2-interferon in the control of malignant pleural effusions. Eur Respir J 1994; 7(18): 412. 37. Schmidt M, Schaarschmidt G, Chemaissani A: Pleurodesis in malignant pleural effusion: Bleomy-
cin vs. Mitoxantrone. Pneumonologie 1997; 51(4): 367-72. 38. Maiche AG, Virkkunen P, Kontkanen T i wsp.: Bleomycin and mitoxantrone in the treatment of malignant pleural effusions. A comparative study. Am J Clin Oncol 1993; 16(1): 50-53. 39. Ong KC, Indumathi V, Raghuram J i wsp.: A comparative study of pleurodesis using talc and bleomycin in the management of malignant pleural effusions. Respirology 2000; 5: 99-103. 40. Hsu WH, Chiang CD, Chen CY i wsp.: Ultrasound- guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion. Jpn J Clin Oncol 1998; 28(3): 187-91. 41. Moores DW: Malignant pleural effusion. Semin Oncol 1991; 18(Suppl.2): 59-61. 42. Tattersall M: Pleural effusions. Curr Opin Oncol 1992; 4(4): 642-46. 43. Martinez-Moragon E, Aparicio J, Rogado MC i wsp.: Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin. Eur Respir J 1997; 10(10): 2380-83. 44. Patz EF, McAdams HP, Erasmus JJ i wsp.: Sclerotherapy for malignant pleural effusions. A prospective randomized trial of Bleomycin vs Doxycycline with small-bore catheter drainage. Chest 1998; 113(5): 1305-11. 45. Emad A, Rezaian GR: Treatment of Malignant Pleural Effusions with a Combination of Bleomycin and Tetracycline. A comparison of Bleomycin or Tetracycline Alone versus a Combination of Bleomycin and Tetracycline. Cancer 1996; 78(12): 24982501. 46. Ross RT, Burnett CM: Talc pleurodesis: a new technique. Am Surg 2001; 67(5): 467-68. 47. Cardillo G, Facciolo F, Carbone L i wsp.: Longterm follow-up of video-assisted talc pleurodesis in malignant recurrrent pleural effusions. Eur J Cardiothorac Surg 2002; 21: 302-06. 48. Milanez JRC, Vargas FS, Werebe EC i wsp.: Thoracoscopy Talc Poudrage. A 15-Year Experience. Chest 2001; 119: 801-06. 49. Saffran L, Ost DE, Fein AM i wsp.: Outpatient Pleurodesis of Malignant Pleural Effusions Using a Small-Bore Pigtail Catheter. Chest 2000; 118: 41721. 50. Bloom AI, Wilson MW, Kerlan RK i wsp: Talc pleurodesis through small-bore percutaneus tubes. Cardivasc Intervent Radiol 1999; 22(5): 433-36. 51. Marom EM, Patz EF, Erasmus JJ i wsp.: Malignant pleural effusions: treatment with small-borecatheter thoracostomy and talc pleurodesis. Radiology 1999; 210(1): 277-81. 52. Vidyasagar MS, Ramanujam AS, Fernandes DJ i wsp.: Vincristine (Vinca-Alkaloid) as a Sclerosing Agent for Malignant Pleural Effusions. Acta Oncologica 1999; 38(8): 1017-20. 53. Macaulay V, O’Byrne KJ, Saunders MP i wsp.: Phase I Study of Intrapleural Batimastat (BB-94), a Matrix Metalloproteinase Inhibitor, in the Treatment of Malignant Pleural Effusions. Clinical Cancer Research 1999; 5: 513-20.